Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase

There is no treatment for the neurodegenerative disorder Huntington disease (HD). Cystamine is a candidate drug; however, the mechanisms by which it operates remain unclear. We show here that cystamine increases levels of the heat shock DnaJ-containing protein 1b (HSJ1b) that are low in HD patients....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Borrell-Pagès, Maria, Canals, Josep M., Cordelières, Fabrice P., Parker, J. Alex, Pineda, José R., Grange, Ghislaine, Bryson, Elzbieta A., Guillermier, Martine, Hirsch, Etienne, Hantraye, Philippe, Cheetham, Michael E., Néri, Christian, Alberch, Jordi, Brouillet, Emmanuel, Saudou, Frédéric, Humbert, Sandrine
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2006
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1430359/
https://ncbi.nlm.nih.gov/pubmed/16604191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI27607
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky